Lower incidence of hepatic metastases of colorectal cancer in patients with chronic liver diseases: meta-analysis

Hepatogastroenterology. 2013 Jul-Aug;60(125):1164-8. doi: 10.5754/hge11561.

Abstract

Background/aims: The rarity of metastatic malignancy in injured liver has been noticed. This meta-analysis evaluates the difference in occurrence of metastatic colorectal cancer in healthy and chronically injured liver.

Methodology: Literature search of occurrence of metastatic colorectal cancer in chronically injured liver opposed to healthy liver was conducted. Chronically injured/damaged liver included cirrhosis, steatosis or fatty liver and infection with Hepatitis virus B or C.

Results: A total of 7 retrospective studies between 1992 and 2010 matched the selection criteria with total of 4049 patients. Results suggest significantly lower incidence of colorectal metastasis in chronically injured liver (Pooled odds ratio = 0.260 (95% CI = 0.18 to 0.38); χ² (test odds ratio differs from 1) = 45.90 (df = 1); p <0.0001).

Conclusions: Patients with chronic liver injury have significantly lower occurrence of hepatic metastasis of primary colorectal cancer than the patients with healthy liver.

Publication types

  • Meta-Analysis

MeSH terms

  • Colorectal Neoplasms / pathology*
  • Fatty Liver / complications
  • Galectin 3 / physiology
  • Hepatitis B, Chronic / complications
  • Hepatitis C, Chronic / complications
  • Humans
  • Incidence
  • Liver Cirrhosis / complications
  • Liver Diseases / complications*
  • Liver Neoplasms / epidemiology
  • Liver Neoplasms / secondary*
  • Metalloproteases / physiology
  • Retrospective Studies
  • Tissue Inhibitor of Metalloproteinases / physiology

Substances

  • Galectin 3
  • Tissue Inhibitor of Metalloproteinases
  • Metalloproteases